Neoplasm by Special Category — Trials

Neoplasm by Special Category — Trials · CancerIndex

Clinical trials

Registered studies

95,726 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 351–400 of 2,612 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03386513	Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN	active not recruiting	Phase 1 / Phase 2	179	AbbVieINDUSTRY	6	Sep 4, 2026	clinicaltrials
NCT03964090	Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS)	active not recruiting	Phase 2	48	National Cancer Institute (NCI)NIH	1	Sep 4, 2026